MktsMarkets

Dianthus Therapeutics, Inc.
NASDAQ: DNTHKey statistics
DNTH News
Stories mentioning DNTH from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 284.00 | 396.00 | 193.00 | 1,163 | 1,326 | 2,172 | 1,863 | |
| Cost of Goods Sold | ||||||||
| Gross Profit | 0.00 | |||||||
| Operating Expenses | ||||||||
| Research & Development | 34,528 | 59,895 | 32,489 | 26,251 | 27,003 | 26,413 | 25,544 | 18,070 |
| Sales General & Admin | ||||||||
| Total Operating Expenses | 46,996 | 69,825 | 40,684 | 35,120 | 34,340 | 33,242 | 32,072 | 24,067 |
| Operating Income (Loss) | (46,533) | (69,541) | (40,288) | (34,927) | (33,177) | (31,916) | (29,900) | (22,204) |
| Interest Income | 5,047 | 4,412 | 1,347 | 2,305 | 1,892 | 1,253 | 2,104 | 4,286 |
| Interest Expense | ||||||||
| Other Expense | (249.00) | (409.00) | (360.00) | (107.00) | (98.00) | (382.00) | 22.00 | (80.00) |
| Pretax Income | ||||||||
| Tax Provision | ||||||||
| Net Income (Loss) | (40,834) | (64,432) | (36,765) | (31,629) | (29,511) | (28,440) | (25,174) | (17,607) |
| Earnings Per Share (Basic) | (0.85) | (1.67) | (0.97) | (0.88) | (0.82) | (0.85) | (0.74) | (0.51) |
| Earnings Per Share (Diluted) | (0.85) | (1.67) | (0.97) | (0.88) | (0.82) | (0.85) | (0.74) | (0.51) |
| Weighted Average Shares Outstanding (Basic) | 48,033 | 38,618 | 37,794 | 35,822 | 35,791 | 33,314 | 34,237 | 34,227 |
| Weighted Average Shares Outstanding (Diluted) | 48,033 | 38,618 | 37,794 | 35,822 | 35,791 | 33,314 | 34,237 | 34,227 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About DNTH
Dianthus Therapeutics, Inc. (NASDAQ: DNTH) is a stock listed on the Nasdaq Stock Market under the ticker symbol DNTH. It last traded at $89.30 (Nov 11, 2026, 4:00 PM ET), up 0.6% on the day. That gives Dianthus Therapeutics a market capitalisation of $5.0B.
Over the past 52 weeks DNTH has traded between $34.29 and $117.88.
For the quarter ended Mar 31, 2026 it reported a net loss of $40.8M.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | — | -$40.8M | — |
| Dec 31, 2025 | $284.0K | -$64.4M | -22687.3% |
| Sep 30, 2025 | $396.0K | -$36.8M | -9284.1% |
| Jun 30, 2025 | $193.0K | -$31.6M | -16388.1% |
From Dianthus Therapeutics’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…